CELEX: 62019TA0883
Language: en
Date: 2020-12-16 00:00:00
Title: Case T-883/19: Judgment of the General Court of 16 December 2020 — Gustopharma Consumer Health v EUIPO — Helixor Heilmittel (HELIX ELIXIR) (EU trade mark — Opposition proceedings — Application for the EU word mark HELIX ELIXIR — Earlier EU word mark HELIXOR — Relative ground for refusal — Likelihood of confusion — Article 8(1)(b) of Regulation (EC) No 207/2009 (now Article 8(1)(b) of Regulation (EU) 2017/1001))

15.2.2021   
            
            
               EN
            
            
               Official Journal of the European Union
            
            
               C 53/39
            
         
      Judgment of the General Court of 16 December 2020 — Gustopharma Consumer Health v EUIPO — Helixor Heilmittel (HELIX ELIXIR)
      (Case T-883/19) (1)
      
      (EU trade mark - Opposition proceedings - Application for the EU word mark HELIX ELIXIR - Earlier EU word mark HELIXOR - Relative ground for refusal - Likelihood of confusion - Article 8(1)(b) of Regulation (EC) No 207/2009 (now Article 8(1)(b) of Regulation (EU) 2017/1001))
      (2021/C 53/52)
      Language of the case: English
      
         Parties
      
      
         Applicant: Gustopharma Consumer Health, SL (Madrid, Spain) (represented by: A. Gómez López and J. Mora Cortés, lawyers)
      
         Defendant: European Union Intellectual Property Office (represented by: L. Rampini and V. Ruzek, acting as Agents)
      
         Other party to the proceedings before the Board of Appeal of EUIPO, intervener before the General Court: Helixor Heilmittel GmbH (Rosenfeld, Germany) (represented by: J. Klink, lawyer)
      
         Re:
      
      Action brought against the decision of the First Board of Appeal of EUIPO of 23 October 2019 (Case R 100/2019-1) relating to opposition proceedings between Helixor Heilmittel and Gustopharma Consumer Health.
      
         Operative part of the judgment
      
      The Court:
      
                  1.
               
               
                  Dismisses the action;
               
            
                  2.
               
               
                  Orders Gustopharma Consumer Health, SL, to pay the costs.
               
            
         (1)  OJ C 68, 2.3.2020.